✦ LIBER ✦

A Randomized Placebo-Controlled Trial of a Humanized Monoclonal Antibody to α4 Integrin in Active Crohn's Disease

✍ Scribed by Fiona H. Gordon; Clement W.Y. Lai; Mark I. Hamilton; Miles C. Allison; Emmanuel D. Srivastava; Marilyn G. Fouweather; Stephen Donoghue; Carol Greenlees; Javaid Subhani; Peter L. Amlot; Roy E. Pounder

Book ID: 119756297
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 245 KB
Volume: 121
Category: Article
ISSN: 0016-5085
DOI: 10.1053/gast.2001.26260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective treatment of active Crohn's di

Effective treatment of active Crohn's disease with humanized monoclonal antibody MRA to interleukin-6 receptor: A randomized placebo-controlled trial

✍ Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

✍ William J. Sandborn; Brian Feagan; Graham Radford-Smith; Agota Kovacs; Robert En 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A randomized controlled trial of CDP571,

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Treatment of Active Crohn's Disease With

Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin

✍ Feagan, Brian G.; Greenberg, Gordon R.; Wild, Gary; Fedorak, Richard N.; Paré, P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 856 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des